Research and Development

Life Healthcare Communications has made four new appointments, adding to its client service, creative and digital teams. Vicki Marsh joins …

The potential benefits of standardisation in the conduct of an increasingly global clinical research effort are enormous. The promise of …

Faster study set-up times, reduced bureaucracy and timely patient recruitment – these things are central to the success of commercial …

They were running hand in hand, and the Queen went so fast that it was all she could do to …

Skyrocketing clinical development costs are bad news for everyone, from pharmaceutical companies to patients. That’s why it’s crucial we find …

The pharmaceutical industry is expanding worldwide. For the last few years, the emerging markets that offer the dynamics of growth …

Boehringer Ingelheim is investing $65 million for an early-stage research and development centre in the US. The new 72,000 sq.ft. …

Changes to both post-marketing and clinical trial requirements

The roles and responsibilities of an EEA Qualified Person for Pharmacovigilance are based on the current Directive 2001/83/EC and Vol …

Joachim Christ will join Merck KGaA on 1 January next year as its new head of corporate controlling. Christ, 46, …

Lemtrada has beaten Merck Serono’s multiple sclerosis treatment Rebif in a new head-to-head trial, paving the way for regulatory submission …

Rock medical communications has appointed journalist and medical writer Mark Greener as editorial director.  Mark spent a decade in the …

When Richard Barker, the ABPI’s director general decided to step down in May this year after six and a half …

Bristol-Myers Squibb and Pfizer have suffered a setback in their attempts to cement Eliquis’ place in the $20 billion market …

Genzyme, a Sanofi company, has appointed William Sibold as head of multiple sclerosis and Rogério Vivaldi as head of rare …